Oncimmune Holdings (LSE:ONC) Enterprise Value : £19.03 Mil (As of Jun. 04, 2024)

Oncimmune Holdings Enterprise Value Chart

Oncimmune Holdings Annual Data
	Trend	May14	May15	May16	May17	May18	May19	May20	May21	May22	Aug23
Enterprise Value		Get a 7-Day Free Trial					53.15	74.20	144.96	75.89	19.29

Oncimmune Holdings Semi-Annual Data
	May14	Nov14	May15	Nov15	May16	Nov16	May17	Nov17	May18	Nov18	May19	Nov19	May20	Nov20	May21	Nov21	May22	Feb23	Aug23	Feb24
Enterprise Value	Get a 7-Day Free Trial															123.26	75.89	35.74	19.29	20.29

Competitive Comparison of Oncimmune Holdings's Enterprise Value

For the Biotechnology subindustry, Oncimmune Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncimmune Holdings's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncimmune Holdings's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Oncimmune Holdings's Enterprise Value falls into.

Oncimmune Holdings Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Oncimmune Holdings's Enterprise Value for the fiscal year that ended in Aug. 2023 is calculated as

Oncimmune Holdings's Enterprise Value for the quarter that ended in Feb. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncimmune Holdings  (LSE:ONC) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Oncimmune Holdings's EV-to-EBIT for today is

Oncimmune Holdings's current Enterprise Value is £19.03 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Oncimmune Holdings's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was £-2.70 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Oncimmune Holdings's EV-to-EBITDA for today is:

Oncimmune Holdings's current Enterprise Value is £19.03 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Oncimmune Holdings's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 was £-2.34 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Oncimmune Holdings's EV-to-Revenue for today is:

Oncimmune Holdings's current Enterprise Value is £19.03 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Oncimmune Holdings's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 was £1.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncimmune Holdings Enterprise Value Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncimmune Holdings (LSE:ONC) Business Description